Responses
Poster Presentation
Rheumatoid arthritis - anti-TNF therapy
THU0215 Establishing Cut-Off of Infliximab and Anti-Infliximab Antibody Levels Using a Commercial Elisa in Patients with Rheumatoid Arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.